- Home
- PGEN vs ZIMV Comparison
PGEN vs ZIMV Comparison
Compare PGEN & ZIMV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- ZIMV
- Stock Information
- Founded
- PGEN 1998
- ZIMV 2021
- Country
- PGEN United States
- ZIMV United States
- Employees
- PGEN N/A
- ZIMV N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PGEN Health Care
- ZIMV Health Care
- Exchange
- PGEN Nasdaq
- ZIMV Nasdaq
- Market Cap
- PGEN 512.5M
- ZIMV 355.5M
- IPO Year
- PGEN N/A
- ZIMV N/A
- Fundamental
- Price
- PGEN $1.74
- ZIMV $11.98
- Analyst Decision
- PGEN Buy
- ZIMV Hold
- Analyst Count
- PGEN 5
- ZIMV 1
- Target Price
- PGEN $7.00
- ZIMV N/A
- AVG Volume (30 Days)
- PGEN 2.0M
- ZIMV 150.8K
- Earning Date
- PGEN 05-13-2025
- ZIMV 05-07-2025
- Dividend Yield
- PGEN N/A
- ZIMV N/A
- EPS Growth
- PGEN N/A
- ZIMV N/A
- EPS
- PGEN N/A
- ZIMV N/A
- Revenue
- PGEN $3,963,000.00
- ZIMV $449,749,000.00
- Revenue This Year
- PGEN N/A
- ZIMV $3.38
- Revenue Next Year
- PGEN $420.64
- ZIMV $0.90
- P/E Ratio
- PGEN N/A
- ZIMV N/A
- Revenue Growth
- PGEN N/A
- ZIMV N/A
- 52 Week Low
- PGEN $0.65
- ZIMV $11.65
- 52 Week High
- PGEN $2.17
- ZIMV $22.40
- Technical
- Relative Strength Index (RSI)
- PGEN 51.69
- ZIMV 33.48
- Support Level
- PGEN $1.66
- ZIMV $11.85
- Resistance Level
- PGEN $1.95
- ZIMV $12.86
- Average True Range (ATR)
- PGEN 0.18
- ZIMV 0.60
- MACD
- PGEN -0.03
- ZIMV -0.09
- Stochastic Oscillator
- PGEN 30.36
- ZIMV 15.07
Stock Price Comparison Chart: PGEN vs ZIMV
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.